Multiple sclerosis (MS) is a debilitating neuroimmunological and neurodegenerative disease (MS [MIM 126200]) and is estimated to affect 400 000 individuals in the United States alone. Numerous ...

Multiple sclerosis (MS [MIM 126200]) is a neurodegenerative autoimmune disease characterized by demyelination within the central nervous system (CNS). Demyelination and the resulting formation of scar ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Multiple sclerosis can affect many areas of your daily life, including dental care. Symptoms of multiple sclerosis and the medications you take for these symptoms can lead to an increased need for ...

The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...

Multiple sclerosis (MS) is a condition that affects your brain and spinal cord. It damages the myelin sheath, the tissue that surrounds and protects your nerve cells. This damage blocks or slows down ...

Multiple sclerosis (MS) and Lyme disease are diseases that stem from very different causes. MS is a life-long autoimmune condition that disrupts the communication between your brain and your body.

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

Sanofi (SNY) stock is in focus as the company agrees to acquire Dynavax Technologies (DVAX) and the FDA rejects its multiple ...